1. Home
  2. AVDL vs NTB Comparison

AVDL vs NTB Comparison

Compare AVDL & NTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • NTB
  • Stock Information
  • Founded
  • AVDL 2015
  • NTB 1858
  • Country
  • AVDL Ireland
  • NTB Bermuda
  • Employees
  • AVDL N/A
  • NTB N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • NTB Commercial Banks
  • Sector
  • AVDL Health Care
  • NTB Finance
  • Exchange
  • AVDL Nasdaq
  • NTB Nasdaq
  • Market Cap
  • AVDL 1.5B
  • NTB 1.8B
  • IPO Year
  • AVDL 1996
  • NTB 2016
  • Fundamental
  • Price
  • AVDL $18.57
  • NTB $42.31
  • Analyst Decision
  • AVDL Buy
  • NTB Hold
  • Analyst Count
  • AVDL 10
  • NTB 3
  • Target Price
  • AVDL $18.94
  • NTB $50.00
  • AVG Volume (30 Days)
  • AVDL 4.4M
  • NTB 207.3K
  • Earning Date
  • AVDL 11-11-2025
  • NTB 10-28-2025
  • Dividend Yield
  • AVDL N/A
  • NTB 4.71%
  • EPS Growth
  • AVDL N/A
  • NTB 14.60
  • EPS
  • AVDL N/A
  • NTB 4.96
  • Revenue
  • AVDL $221,075,000.00
  • NTB $588,897,000.00
  • Revenue This Year
  • AVDL $64.21
  • NTB $3.31
  • Revenue Next Year
  • AVDL $30.80
  • NTB N/A
  • P/E Ratio
  • AVDL N/A
  • NTB $8.55
  • Revenue Growth
  • AVDL 132.35
  • NTB 2.95
  • 52 Week Low
  • AVDL $6.38
  • NTB $34.77
  • 52 Week High
  • AVDL $18.65
  • NTB $46.89
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 79.97
  • NTB 46.22
  • Support Level
  • AVDL $13.83
  • NTB $41.78
  • Resistance Level
  • AVDL $18.65
  • NTB $42.45
  • Average True Range (ATR)
  • AVDL 0.59
  • NTB 0.77
  • MACD
  • AVDL 0.43
  • NTB 0.11
  • Stochastic Oscillator
  • AVDL 97.93
  • NTB 79.52

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About NTB Bank of N.T. Butterfield & Son Limited (The) Voting

Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, Cayman Islands, the Channel Islands and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.

Share on Social Networks: